150 related articles for article (PubMed ID: 7909226)
1. High levels of circulating RNA in patients with symptomatic HIV-1 infection.
Baumberger C; Kinloch-de-Loës S; Yerly S; Hirschel B; Perrin L
AIDS; 1993 Nov; 7 Suppl 2():S59-64. PubMed ID: 7909226
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells.
Stellbrink HJ; van Lunzen J; Hufert FT; Fröschle G; Wolf-Vorbeck G; Zöllner B; Albrecht H; Greten H; Racz P; Tenner-Racz K
AIDS; 1997 Jul; 11(9):1103-10. PubMed ID: 9233456
[TBL] [Abstract][Full Text] [Related]
3. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
AIDS; 1993 Nov; 7 Suppl 2():S65-71. PubMed ID: 7909227
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease.
Verhofstede C; Reniers S; Van Wanzeele F; Plum J
AIDS; 1994 Oct; 8(10):1421-7. PubMed ID: 7529507
[TBL] [Abstract][Full Text] [Related]
5. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
Ostrowski SR; Katzenstein TL; Thim PT; Pedersen BK; Gerstoft J; Ullum H
J Infect Dis; 2005 Feb; 191(3):348-57. PubMed ID: 15633093
[TBL] [Abstract][Full Text] [Related]
6. Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy.
Andreoni M; Parisi SG; Sarmati L; Nicastri E; Ercoli L; Mancino G; Sotgiu G; Mannazzu M; Trevenzoli M; Tridente G; Concia E; Aceti A
AIDS; 2000 Jan; 14(1):23-9. PubMed ID: 10714564
[TBL] [Abstract][Full Text] [Related]
7. Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV-1-infected individuals.
Bieniasz PD; Ariyoshi K; Bourelly MA; Bloor S; Foxall RB; Harwood EC; Weber JN
AIDS; 1993 Jun; 7(6):803-6. PubMed ID: 8103340
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.
Yerly S; Chamot E; Hirschel B; Perrin LH
J Infect Dis; 1992 Aug; 166(2):269-76. PubMed ID: 1353103
[TBL] [Abstract][Full Text] [Related]
9. Diurnal and short-term stability of HIV virus load as measured by gene amplification.
Holodniy M; Mole L; Winters M; Merigan TC
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):363-8. PubMed ID: 7907661
[TBL] [Abstract][Full Text] [Related]
10. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
Molina JM; Ferchal F; Chevret S; Barateau V; Poirot C; Morinet F; Modai J
AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
[TBL] [Abstract][Full Text] [Related]
11. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA.
Lin HJ; Haywood M; Hollinger FB
J Clin Microbiol; 1996 Feb; 34(2):329-33. PubMed ID: 8789009
[TBL] [Abstract][Full Text] [Related]
12. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
[TBL] [Abstract][Full Text] [Related]
13. Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).
Stellbrink HJ; van Lunzen J; Westby M; O'Sullivan E; Schneider C; Adam A; Weitner L; Kuhlmann B; Hoffmann C; Fenske S; Aries PS; Degen O; Eggers C; Petersen H; Haag F; Horst HA; Dalhoff K; Möcklinghoff C; Cammack N; Tenner-Racz K; Racz P
AIDS; 2002 Jul; 16(11):1479-87. PubMed ID: 12131185
[TBL] [Abstract][Full Text] [Related]
14. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.
Vitone F; Gibellini D; Schiavone P; Re MC
J Clin Virol; 2005 Jul; 33(3):194-200. PubMed ID: 15911440
[TBL] [Abstract][Full Text] [Related]
15. [The quantification of human immunodeficiency virus viremia in patients with rapid and slow progression of the disease].
Bravo R; Soriano V; Martín R; del Romero J; Dronda F; Gutiérrez M; Martínez P; Valencia E; Moreno V; Laguna F
Med Clin (Barc); 1995 Apr; 104(14):530-4. PubMed ID: 7776732
[TBL] [Abstract][Full Text] [Related]
16. Cellular and plasma viral load in patients infected with HIV-2.
Simon F; Matheron S; Tamalet C; Loussert-Ajaka I; Bartczak S; Pépin JM; Dhiver C; Gamba E; Elbim C; Gastaut JA
AIDS; 1993 Nov; 7(11):1411-7. PubMed ID: 7904166
[TBL] [Abstract][Full Text] [Related]
17. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.
Bagnarelli P; Menzo S; Valenza A; Manzin A; Giacca M; Ancarani F; Scalise G; Varaldo PE; Clementi M
J Virol; 1992 Dec; 66(12):7328-35. PubMed ID: 1433521
[TBL] [Abstract][Full Text] [Related]
18. Plasma viraemia as a marker of viral replication in HIV-infected individuals.
Escaich S; Ritter J; Rougier P; Lepot D; Lamelin JP; Sepetjan M; Trepo C
AIDS; 1991 Oct; 5(10):1189-94. PubMed ID: 1723881
[TBL] [Abstract][Full Text] [Related]
19. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 DNA and RNA kinetics in primary HIV infection.
Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
